Pharmacovigilance Global Market Report 2022

Publish Date: Jun 2022

Report Code: TBR2059A

Publisher: TBRC (Publisher)

Single User License: $5000

Explore Our Services

Already a member? Login here.

Report Highlights

Including: 1) By Type: Spontaneous Reporting; Intensified ADR Reporting; Targeted Spontaneous Reporting; Cohort Event Monitoring; EHR Mining
2) By Service Provider: In-House; Contract Outsourcing
3) By Process Flow: Case Data Management; Signal Detection; Risk Management System
4) By Clinical Trial Phases: Preclinical; Phase I; Phase II; Phase III; Phase IV
5) By End User: Hospitals; Pharmaceutical Companies; Other End Users
Covering: Accenture; Cognizant; Labcorp Drug Development; IQVIA; IQVIA; Parexel International Corporation

Pharmacovigilance Global Market Report 2022 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global pharmacovigilance market.

This report focuses on pharmacovigilance market which is experiencing strong growth. The report gives a guide to the pharmacovigilance market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the pharmacovigilance market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Pharmacovigilance Market global report from the Business Research Company answers all these questions and many more. The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmacovigilance market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The pharmacovigilance market section of the report gives context. It compares the pharmacovigilance market with other segments of the pharmacovigilance market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, pharmacovigilance market indicators comparison.

Scope

Markets Covered:

  • By Type: Spontaneous Reporting; Intensified ADR Reporting; Targeted Spontaneous Reporting; Cohort Event Monitoring; EHR Mining
  • By Service Provider: In-House; Contract Outsourcing
  • By Process Flow: Case Data Management; Signal Detection; Risk Management System
  • By Clinical Trial Phases: Preclinical; Phase I; Phase II; Phase III; Phase IV
  • By End User: Hospitals; Pharmaceutical Companies; Other End Users

Companies Mentioned: Accenture; Cognizant; Labcorp Drug Development; IQVIA; Parexel International Corporation

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2 : Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3 : Global Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4 : Global Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5 : Global Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6 : Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7 : Global Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8 : Global Pharmacovigilance Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9 : Global Pharmacovigilance Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10 : Asia-Pacific, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11 : Asia-Pacific, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12 : China, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13 : China, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14 : India, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15 : India, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16 : Japan, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17 : Japan, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18 : Australia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19 : Australia, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20 : Indonesia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21 : Indonesia, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22 : South Korea, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23 : South Korea, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24 : Western Europe, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25 : Western Europe, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26 : UK, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27 : UK, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28 : Germany, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 29 : Germany, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 30 : France, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 31 : France, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 32 : Eastern Europe, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 33 : Eastern Europe, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 34 : Russia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 35 : Russia, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 36 : North America, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 37 : North America, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 38 : USA, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 39 : USA, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 40 : South America, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 41 : South America, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 42 : Brazil, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 43 : Brazil, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 44 : Middle East, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 45 : Middle East, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 46 : Africa, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 47 : Africa, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 48 : Accenture Financial Performance
  • Table 49 : Cognizant Financial Performance
  • Table 50 : Labcorp Drug Development Financial Performance
  • Table 51 : IQVIA Financial Performance
  • Table 52 : Parexel International Corporation Financial Performance
  • Figure 1 : Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2 : Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3 : Global Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4 : Global Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5 : Global Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6 : Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7 : Global Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8 : Global Pharmacovigilance Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9 : Global Pharmacovigilance Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10 : Asia-Pacific, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11 : Asia-Pacific, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12 : China, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13 : China, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14 : India, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15 : India, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16 : Japan, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17 : Japan, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18 : Australia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19 : Australia, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20 : Indonesia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21 : Indonesia, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22 : South Korea, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23 : South Korea, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24 : Western Europe, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25 : Western Europe, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26 : UK, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27 : UK, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28 : Germany, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 29 : Germany, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 30 : France, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 31 : France, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 32 : Eastern Europe, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 33 : Eastern Europe, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 34 : Russia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 35 : Russia, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 36 : North America, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 37 : North America, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 38 : USA, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 39 : USA, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 40 : South America, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 41 : South America, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 42 : Brazil, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 43 : Brazil, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 44 : Middle East, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 45 : Middle East, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 46 : Africa, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 47 : Africa, Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 48 : Accenture Financial Performance
  • Figure 49 : Cognizant Financial Performance
  • Figure 50 : Labcorp Drug Development Financial Performance
  • Figure 51 : IQVIA Financial Performance
  • Figure 52 : Parexel International Corporation Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Pharmacovigilance Global Market Report 2022